FDA Inspection 982273 — Andrea Schilling, MD
The FDA completed an inspection of Andrea Schilling, MD on June 10, 2016 in Santiago. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 10, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Santiago (Chile)
Additional Details
Clinical Investigator (CI)